ctrl K

Watchlist Price Alert

Catalyst Biosciences Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

15.97

-1.02 (-6.00%)

At close: Jun 27, 2025, 3:59 PM

17.08

6.98%

After-hours: Jun 27, 2025, 05:22 PM EDT

Catalyst Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	105.76M	794K	7.34M	20.95M	n/a	6K	1.02M	399K
Cost of Revenue	3.88M	798K	7.38M	9.16M	43.86M	21.47M	12.85M	10.55M
Gross Profit	101.87M	-4K	-42K	11.79M	-43.86M	-21.47M	-11.83M	-10.16M
Operating Income	16.16M	-8.61M	-87.89M	-57.37M	-57.28M	-33.82M	-21.82M	-20.42M
Interest Income	n/a	537K	39K	1.13M	2.1M	3.77M	261K	3.47M
Pretax Income	23.22M	-7.89M	-87.93M	-56.24M	-55.18M	-30.05M	-21.56M	-16.95M
Net Income	28.54M	-8.24M	-87.89M	-55.54M	-52.89M	-30.05M	-21.56M	-16.95M
Selling & General & Admin	73.62M	17.37M	18.96M	16.18M	13.42M	12.35M	9.99M	9.26M
Research & Development	12.02M	13.04M	68.89M	52.98M	43.86M	21.47M	12.85M	11.55M
Other Expenses	66K	n/a	-78K	568K	-46K	1.65M	261K	86K
Operating Expenses	85.71M	30.4M	87.85M	69.16M	57.28M	33.83M	22.84M	20.82M
Interest Expense	n/a	717K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	57.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	89.59M	31.2M	95.23M	78.32M	57.28M	33.83M	22.84M	20.82M
Income Tax Expense	-5.32M	348K	-39K	-699K	-2.29M	3.77M	-173K	3.08M
Shares Outstanding (Basic)	85.09M	31.55M	30.64M	19.18M	12M	11.21M	3.42M	778.78K
Shares Outstanding (Diluted)	102.29M	31.55M	30.64M	19.18M	12M	11.21M	3.42M	778.78K
EPS (Basic)	0.34	-0.26	-2.87	-2.9	-4.41	-2.68	-6.3	-21.76
EPS (Diluted)	0.28	-0.26	-2.87	-2.9	-4.41	-2.68	-6.3	-21.76
EBITDA	16.16M	-52.15M	-87.6M	-57.37M	-57.28M	-33.82M	-21.82M	-16.95M
EBIT	n/a	-7.18M	-87.97M	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	-43.54M	290K	138K	146K	149K	173K	389K